Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MPS_NOVA

Financiado

Cerrado

MPS NOVA Hub: Advanced Microphysiological Systems and Pluripotent Stem Cell Tech...

MPS NOVA Hub: Advanced Microphysiological Systems and Pluripotent Stem Cell Technologies to Unveil Chronic Disease Mechanisms and Host-Microbe Interactions Mitigating the current rise in chronic diseases and effectively addressing the enduring challenges posed by infectious diseases are pressing concerns in 21st-century healthcare. These challenges demand innovative research approach... ver más

30/09/2027

UNL

Presupuesto desconocido

Líder del proyecto

UNIVERSIDADE NOVA DE LISBOA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-10-01

HORIZON-WIDERA-2023-ACCESS-02-02: Twinning Green Deal ExpectedOutcome:For the first time this Twinning call adopts a partially directional approach allowi...

Innovación

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

UNL

Lider

Proyectos interesantes

COSMIC

Medical Technol...

Data Science

4M€ Cerrado

EUIN2015-62860

Medical Technol...

Data Science

20K€ Cerrado

IMMEDIATE

Medical Technol...

Data Science

6M€ Cerrado

ERICA

Medical Technol...

Data Science

2M€ Cerrado

SYSCID

Medical Technol...

Data Science

16M€ Cerrado

MAPPING_NCD

Medical Technol...

Data Science

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 35 meses Fecha Inicio: 2024-10-01
Fecha Fin: 2027-09-30

Líder del proyecto

UNIVERSIDADE NOVA DE LISBOA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Mitigating the current rise in chronic diseases and effectively addressing the enduring challenges posed by infectious diseases are pressing concerns in 21st-century healthcare. These challenges demand innovative research approaches, and microphysiological systems (MPS) have emerged as promising tools for the study of these conditions, as they are capable of replicating near-native human physiology, with significant potential for precision medicine. However, the adoption of MPS technology in Portugal lags behind, primarily due to the high expertise required.To bridge this gap, we will establish a European collaborative network, MPS_NOVA, under the coordination of the University Nova of Lisbon (UNL). This will bring together leading European institutions specializing in MPS and stem cell research, including UKJ (Germany), MDC-BIMSB (Germany), and FHT (Italy). These will collectively offer a broad range of expertise and approaches in the field of MPS and stem cell methodologies, which will fortify UNL's existing multidisciplinary knowledge and expertise, foster best practices in research and training, and expand collaborative networks. By doing so, it will enhance the capabilities, excellence, visibility, and reputation of UNL's research, researchers, and research management staff. For this, a variety of network and research activities have been devised, focusing on the integration of these cutting-edge technologies at UNL, by facilitating collaborative projects and promoting knowledge exchange among partners. Key to these achievements is the upskilling of ITQB NOVA and NMS research managers, who will benefit from tailored partner training in HR excellence, effective management strategies and optimized communication.Together, MPS_NOVA will create a European Center of Excellence in MPS and stem cell research in Portugal, driving breakthrough advances in chronic diseases and host-microbe interactions, benefiting basic and applied research, and society at large.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores